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Braillon raises some points for discussion in response to our paper “The use of complementary 
medicine in palliative care in France: an observational cross-sectional study” [1]. Firstly, we concur 
that concepts and phenomena in science need to be demarcated, defined and constantly 
scrutinized. We also agree that the term ‘complementary medicine’ (CM) is fraught at best, with its 
use primarily limited to be a vehicle of convenience for academics and policymakers to discuss any 
healthcare that is not included in mainstream health systems within any given locality [2]. As a term, 
it certainly has limited, if any, value in the context of understanding and providing patient-centred 
health services. CM, as it is used in peer-reviewed literature and health policy, refers to such a broad 
selection of treatments, practices and therapies that any generalized statements about CM are 
difficult, if not impossible [3]. Equally, the subjective classification of CM is often undertaken through 
the sociocultural and personal biases of those applying the classification, whether they be CM 
practitioners, mainstream health professionals, independent researchers or stalwart skeptics. In this 
instance, we have applied a ‘theoretical’ definition of CM [4] – treatments and practices not included 
within national medical curriculum - in response to the identified gap in French health services 
research and policy addressing treatments that are not considered part of mainstream healthcare.  
Braillon rightly emphasizes the importance of evidence for both benefit and safety of healthcare 
accessed by the public. We hold the view that it is the responsibility of the research community to 
serve the wider population by undertaking rigorous research to address any gaps in such evidence 
and, in doing so, inform future evidence-based decision-making. We also believe that research is 
about transparency, the creation of new knowledge and the use of existing knowledge in a new way 
to generate new concepts, methodologies and further understanding. Our research offers readers, 
such as researchers and policymakers, an opportunity to prioritize resources (both human and fiscal) 
based on evidence of use rather than personal bias or conjecture; and in our reckoning the most 
commonly used treatments and practices should be among those prioritized for future research. We 
concede that the practice of medicine has many connotations and one´s perspective of its concepts 
is influenced by the beholder’s paradigmatic stance. As co-authors, we take a rather pragmatic 
stance and view the practice of medicine through the lens of the evidence-based practice model, 
thus involving the conscious and systematic use of several sources of knowledge for decision-
making: the best available knowledge, the professional expertise, experience and wishes of the 
patient concerned, but also the patient´s situation and contextual circumstance [5]. With this in 
mind, we acknowledge Braillon’s interest in homeopathy however we would suggest that, based on 
the evidence presented in our study, aromatherapy (products and practice), Coupeurs de feu, 
osteopathy and vitamins warrant equal or greater attention for further research. Our paper presents 
preliminary clinical research examining some of these practices, but also acknowledges the evidence 
gaps. It is our hope that our research will stimulate academic and government interest in these 
practices and result in knowledge production that strengthens a patient’s capacity to make informed 
healthcare decisions.  
Based on the scarcity of empirical data regarding the use of CM, especially among cancer patients in 
France, we employed a descriptive rationale in our study. Thus, the aim of our paper was to describe 
the use of CM by individuals receiving palliative care in Lyon, France. However, we also 
acknowledged in our paper that this study is restricted to Lyon; a location with its own historical and 
sociocultural factors that may influence health service use. Given the surprisingly high prevalence of 
CM use, we have also raised the question presented by Braillon regarding the degree to which the 
findings from our study are reflective of health service use patterns across France. We look forward 
to future research answering such questions and, rather than speculating based on local data, have 
called for such research to be conducted. We maintain that our work is a first step to elucidate this 
current gap of knowledge and anticipate the new knowledge that will evolve regarding CM use in 
palliative care settings. 
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